- Home
- UPC vs INM Comparison
UPC vs INM Comparison
Compare UPC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPC
- INM
- Stock Information
- Founded
- UPC 1998
- INM 1981
- Country
- UPC China
- INM Canada
- Employees
- UPC 225
- INM N/A
- Industry
- UPC Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- UPC Health Care
- INM Health Care
- Exchange
- UPC Nasdaq
- INM Nasdaq
- Market Cap
- UPC 1.9M
- INM 2.3M
- IPO Year
- UPC 2021
- INM N/A
- Fundamental
- Price
- UPC $0.13
- INM $2.73
- Analyst Decision
- UPC
- INM
- Analyst Count
- UPC 0
- INM 0
- Target Price
- UPC N/A
- INM N/A
- AVG Volume (30 Days)
- UPC 803.8K
- INM 50.0K
- Earning Date
- UPC 01-01-0001
- INM 02-12-2025
- Dividend Yield
- UPC N/A
- INM N/A
- EPS Growth
- UPC N/A
- INM N/A
- EPS
- UPC N/A
- INM N/A
- Revenue
- UPC $26,725,919.00
- INM $4,832,013.00
- Revenue This Year
- UPC N/A
- INM N/A
- Revenue Next Year
- UPC N/A
- INM N/A
- P/E Ratio
- UPC N/A
- INM N/A
- Revenue Growth
- UPC N/A
- INM N/A
- 52 Week Low
- UPC $0.12
- INM $2.42
- 52 Week High
- UPC $4.32
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- UPC 31.23
- INM 34.47
- Support Level
- UPC $0.11
- INM $2.66
- Resistance Level
- UPC $0.17
- INM $2.90
- Average True Range (ATR)
- UPC 0.03
- INM 0.25
- MACD
- UPC 0.02
- INM 0.01
- Stochastic Oscillator
- UPC 9.66
- INM 21.05
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.